Sanara MedTech (NASDAQ:SMTI – Get Free Report) and Envoy Medical (NASDAQ:COCH – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk.
Profitability
This table compares Sanara MedTech and Envoy Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Sanara MedTech | -6.62% | -11.12% | -7.11% |
| Envoy Medical | N/A | N/A | -100.39% |
Earnings & Valuation
This table compares Sanara MedTech and Envoy Medical’s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Sanara MedTech | $64.99 million | 4.29 | -$4.30 million | ($0.52) | -62.21 |
| Envoy Medical | $320,000.00 | 317.28 | -$29.91 million | N/A | N/A |
Insider & Institutional Ownership
8.1% of Sanara MedTech shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 55.2% of Sanara MedTech shares are owned by company insiders. Comparatively, 0.7% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Analyst Ratings
This is a summary of current recommendations and price targets for Sanara MedTech and Envoy Medical, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Sanara MedTech | 0 | 0 | 1 | 0 | 3.00 |
| Envoy Medical | 0 | 0 | 2 | 0 | 3.00 |
Sanara MedTech currently has a consensus target price of $44.00, suggesting a potential upside of 36.01%. Envoy Medical has a consensus target price of $6.00, suggesting a potential upside of 15.83%. Given Sanara MedTech’s higher probable upside, equities analysts plainly believe Sanara MedTech is more favorable than Envoy Medical.
Volatility & Risk
Sanara MedTech has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.68, indicating that its stock price is 168% more volatile than the S&P 500.
Summary
Envoy Medical beats Sanara MedTech on 6 of the 11 factors compared between the two stocks.
About Sanara MedTech
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
About Envoy Medical
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Receive News & Ratings for Sanara MedTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanara MedTech and related companies with MarketBeat.com's FREE daily email newsletter.
